Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03834922
Other study ID # 777500-IMI-PainCare PROMPT
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 24, 2019
Est. completion date June 30, 2022

Study information

Verified date November 2022
Source University of Jena
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

PROMPT aims at improving management of acute and chronic pain by identifying a core set of PROMs (patient reported outcome measures) that are predictive indicators of treatment success in clinical practice and controlled trials. These will not only address pain intensities as well as the functional consequences of pain for individuals but also identify patients at risk of experiencing chronification of acute post-operative pain. Results will help health care professionals to individualize pain management, and thus improve the quality of life of pain patients.


Description:

In order to reach this objective, a non-interventional prospective data collection aiming at reaching a consensus on a core set of PROMs which reliably predict and/or measure success in acute and chronic pain treatments in real life conditions and identifying predictors for chronification of postoperative pain will be conducted (PROMPT NIT-1). Aim of the data collection is to evaluate the abilities of certain PROMs in assessing acute post-surgical pain outcomes in daily routine care of patients after four different surgical procedures: (total knee replacement, breast surgery, sternotomy and surgery related to endometriosis), and to validate selected risk factors for chronification prospectively.


Recruitment information / eligibility

Status Completed
Enrollment 3322
Est. completion date June 30, 2022
Est. primary completion date June 30, 2022
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patient is of consenting age (>18 years old) - Elective surgery - Planned stay in hospital for the surgery - First contact with the patient before surgery - Patient agrees to participate Exclusion Criteria: - Patient is unable to give consent - Cognitive impairment - Questionnaire is not available in a language the patient is fluent in - Patient not willing to answer the follow-up questionnaire

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Prospective data collection
No intervention. It's a prospective data collection.

Locations

Country Name City State
Germany Jena University Hospital Jena Thuringia

Sponsors (22)

Lead Sponsor Collaborator
Prof. Dr. Winfried Meissner Barts & The London NHS Trust, Cancer Center Porto, Portugal, Cardiovascular Center Dedinje, Belgrade, Serbia, Grünenthal GmbH, Hôpital Raymond Poincaré, Hospital Ambroise Paré Paris, Hospital Clínico Universitario de Valladolid, Infirmerie Protestante Lyon, Novartis Pharmaceuticals, Orthopedic Center Santy, Lyon, France, Orthopedic Institute Banjika, Belgrade, Serbia, Oxford University Hospitals NHS Trust, University Hospital Bergmannsheil Bochum, University Hospital Dresden, University Hospital Inselspital, Berne, University Hospital Muenster, University Hospital St Luc, Brussels, University Hospital, Geneva, University of Helsinki, University of Homburg, University of Naples

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary WP 2 - Acute pain: Sensitivity to change For WP2, the primary endpoint will be pain intensity at day 3 (NRS Scale from 0 to 10, 0 being no pain, 10 being worst pain imaginable). This primary endpoint (PROMs) will be used to assess sensitivity to change from POD3 to POD1. 2019 - 2022
Primary WP 3 - Chronification of pain: Incidence of chronic post-surgical pain (CPSP) For WP3, the primary end point will be the incidence of moderate to severe CPSP (Numeric rating scale = 3/10) at 6 months using the average pain on the Brief Pain Inventory Questionnaire. 2019 - 2022
Secondary Objective physical activity and sleep, measured with Actigraph devices Correlation of physical activity data (average no. of steps of days 5 to 7) with PRO "physical function" on day 7; 01/2020 to 12/2021
Secondary Association between other POD7 PROMs and activity/sleep Association between other POD7 PROMs and activity/sleep 01/2020 to 12/2021
Secondary Association between peri-operative processes and activity/sleep Association between peri-operative processes and activity/sleep 01/2020 to 12/2021
Secondary Is decreased activity a predictor for chronic postsurgical pain? Is decreased activity a predictor for chronic postsurgical pain on POM6? 01/2020 to 12/2021
Secondary Do activity trajectories since surgery parallel trajectories of other outcomes? Do activity trajectories since surgery parallel trajectories of other outcomes? 01/2020 to 12/2021
Secondary Correlation of activity difference between POD5-7 and preop with POD7 oucomes Correlation of activity difference between POD5-7 and preop with POD7 oucomes 01/2020 to 12/2021
Secondary Association between ambient light intensity and outcomes on POD7 Association between ambient light intensity and outcomes on POD7 01/2020 to 12/2021
See also
  Status Clinical Trial Phase
Completed NCT05480111 - The Role of Quadratus Lumborum Blocks Following Minimally Invasive Hysterectomy Phase 4
Completed NCT06129305 - Erector Spina Muscle Distance From the Skin at Different Thoracal Elevations
Completed NCT04401826 - Micro-surgical Treatment of Gummy Smile N/A
Recruiting NCT04020133 - the Role of Popliteal Plexus Block in Pain Management After Anterior Cruciate Ligament Reconstruction. N/A
Completed NCT03023462 - Efficacy of an Anterior Quadratus Lumborum Block vs. a TAP-block for Inguinal Hernia Repair N/A
Completed NCT03652103 - Efficiency of Erector Spinae Plane Block For Patients Undergoing Percutaneous Nephrolithotomy Phase 4
Completed NCT03546738 - Spinal Cord Burst Stimulation for Chronic Radicular Pain Following Lumbar Spine Surgery N/A
Recruiting NCT03261193 - ITM + Bupivacaine QLB vs. ITM + Sham Saline QLB for Cesarean Delivery Pain Phase 3
Withdrawn NCT03528343 - Narcotic vs. Non-narcotic Pain Regimens After Pediatric Appendectomy Phase 1/Phase 2
Completed NCT02525133 - Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After Hernioplasty Phase 3
Completed NCT03244540 - Regional Analgesia After Cesarean Section Phase 4
Enrolling by invitation NCT05316168 - Post Operative Pain Management for ACL Reconstruction Phase 3
Recruiting NCT04130464 - Intraperitoneal Infusion of Analgesic for Postoperative Pain Management Phase 4
Enrolling by invitation NCT04574791 - Addition of Muscle Relaxants in a Multimodal Analgesic Regimen for Analgesia After Primary Total Knee Arthroplasty N/A
Completed NCT04526236 - Influence of Aging on Perioperative Methadone Dosing Phase 4
Completed NCT04073069 - Scalp Infiltration With Diprospan Plus Ropivacaine for Postoperative Pain After Craniotomy in Adults Phase 4
Recruiting NCT05351229 - Intrathecal Morphine for Analgesia in Video-assisted Thoracic Surgery Phase 4
Enrolling by invitation NCT05543109 - Ultrasound Guided Psoas Compartment Block vs Suprainguinal Fascia Iliaca Compartment Block N/A
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Completed NCT04919317 - Combination Dexamethasone and Bupivacaine Pain Control in Reduction Mammaplasty Phase 2